Genetic testing: Who should do the testing and what is the role of genetic testing in the setting of celiac disease?
Celiac disease is a remarkable and common immune-mediated disorder determined by both the presence of characteristic HLA alleles (DQ2 and DQ8) and one of the best characterized environmental factors (gliadin) for any common autoimmune disease. The discovery of transglutaminase autoantibodies and the development of assays for these antibodies has allowed the identification of a large number of asymptomatic individuals with autoimmunity and intestinal biopsy evidence of celiac lesions. Further understanding of the sequelae of asymptomatic celiac disease, and the interaction between genetic susceptibility and environmental factors, are likely to alter fundamentally both genetic screening for celiac disease and its therapy.
To access this article, please choose from the options below
Supported by National Institute of Health grants DK 32083, A146374, DK57516; the Diabetes Endocrine Research Center (P30 DK57516); the National Institutes of Health Clinical Research Centers Program (MO1 RR00069, MO1 RR00051); and by K08064605-02 (E.L.).
PII: S0016-5085(05)00182-4
doi:10.1053/j.gastro.2005.02.013
© 2005 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.

